To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects
Status:
COMPLETED
Trial end date:
2023-04-26
Target enrollment:
Participant gender:
Summary
The study is a randomized, double-blind, vehicle-controlled, parallel group, phase 1 study to evaluate the Safety, Tolerability and PK of GT20029 in healthy subjects